A Phase 2b Study
Evaluating Oral VH4524184 Plus Emtricitabine and Tenofovir Alafenamide in treatment-Naïve Persons with HIV-1
Who can join innovate?
Am I Eligible
You MAY be able to join if you:
- Are 18 years or older
- Have HIV-1 infection
- Have never taken HIV medications before
- Have a viral of 1,000 [copies/mL] or higher
- Have a CD4 count of 200 or higher
- Weight>50 Kg (110lbs) if assigned male at birth or >45 Kg (99 lbs) if assigned female female at birth.
You MAY NOT be able to join if you:
- Are pregnant or breastfeeding
- Have moderate or severe liver problems
- Have certain heart rhythm problems
- Are taking medications that affect the study drugs
- Have active serious infections or certain cancers
- Have certain other health problems like hepatitis B or C
For More Info:
Jessica Rivera
Clinical Research Manager
Participants will be compensated for their time